ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,247, issued on Dec. 30.
"Controlled release injectable ondansetron formulations" was invented by Purushothama Narasiyappa (Bengaluru, India), Kiran Kumar Cherukuri (Bengaluru, India), Vivek Vijaya Kumar Joshi (Bengaluru, India), Pradeep Shivakumar (Bengaluru, India) and Sreenivasa Reddy (Bengaluru, India).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a controlled release injectable ondansetron formulation comprising ondansetron or pharmaceutically acceptable salt, derivative or metabolite thereof which releases ondansetron over a period of at least 2 days period from the date of administration and the process for pre...